Use of visual screening methods for cervical cancer screening

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 4, 2002, Pages 701-734

  Wright Jr , Thomas C ^a   Denny, Lynette ^b   Kuhn, Louise ^c   Goldie, Sue ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d HARVARD CENTER FOR RISK ANALYSIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTRONIC SENSOR; ELECTROOPTICAL SENSOR; FEMALE; HUMAN; PAPANICOLAOU TEST; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ACETIC ACID; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; MASS SCREENING; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 0036920332     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(02)00045-1     Document Type: Review

References (63)

1. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-9.
2. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
3. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 1998;91:626-31.
4. Denny L, Kuhn L, Pollack A, Wright Jr TC. Direct visual inspection for cervical cancer screening: An analysis of factors influencing test performance. Cancer 2002;94:1699-707.
5. Denny LA. An Evaluation of Alternative Strategies for the Prevention of Cervical Cancer in Low Resource Setting (PhD Thesis). University of Cape Town, Cape Town, South Africa; 2000.
6. Ismail SM, Colelough AB, Dinnen JS, et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989;298:707-10.
7. Robertson AJ, Anderson JM, Beck JS, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989;42:231-8.
8. Schiller WB. Early diagnosis of carcinoma of the cervix. Surg Gynecol Obstet 1933;66:210-20.
9. Schiller W. Leucoplakia, leucokeratosis, and carcinoma of the cervix. Am J Obstet Gynecol 1938;35:17-38.
10. World Health Organization. Control of cancer of the cervix uteri. Bull World Health Organ 1986;64:607-18.
11. Stemsward J, Eddy D, Luthra U, Stanley K. Plotting a new course for cervical cancer screening in developing countries. World Health Forum 1987;8:42-5.
12. Sehgal A, Singh V, Bhambhani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet 1991;338:282-5.
13. Singh V, Seghal A, Luthra UK. Screening for cervical cancer by direct inspection. BMJ 1992;304:534-5.
14. Nene BM, Deshpande S, Jayant K, et al. Early detection of cervical cancer by visual inspection: A population-based study in rural India. Int J Cancer 1996;68:770-3.
15. Wesley R, Sankaranarayanan R, Mathew B, et al. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997;75:436-40.
16. Sankaranarayanan R, Shyamalakumary B, Wesley R, Sreedevi Amma N, Parkin DM, Nair MK. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer 1999;80:161-3.
17. Megevand E, Denny L, Dehaeck K, Soeters R, Bloch B. Acetic acid visualization of the cervix: An alternative to cytologic screening. Obstet Gynecol 1996;88:383-6.
18. Frisch LE, Milner FH, Ferris DG. Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening [see comments]. J Fam Pract 1994;39:457-60.
19. Slawson DC, Bennett JH, Herman JM. Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: a HARNET (Harrisburg Area Research Network) study. J Fam Pract 1992;35:271-7.
20. Cecchini S, Bonardi R, Mazzotta A, Grazzini G, Iossa A, Ciatto S. Testing cervicography and cervicoscopy as screening tests for cervical cancer. Tumori 1993;79:22-5.
21. Ottaviano M, La Torre P. Examination of the cervix with the naked eye using acetic acid test. Am J Obstet Gynecol 1982;143:139-42.
22. Sankaranarayanan R, Wesley R, Somanathan T, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 1998;83:2150-6.
23. Zimbabwe Project. Visual inspection with acetic acid for cervical-cancer screening. Test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 1999;353:869-73.
24. Denny L, Kuhn L, Pollack A, Wainwright H, Wright Jr TC. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000;89:826-33.
25. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
26. Sellors JW, Jeronimo J, Sankaranarayanan R, Wright TC, Howard M, Blumenthal PD. Assessment of the cervix after acetic acid wash: Inter-rater agreement using photographs. Obstet Gynecol 2002;99:635-40.
27. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd Edition. Washington, DC: US Department of Health and Human Services; 1996.
28. Schneider DL, Burke L, Wright TC, et al. Can cervicography be improved? An evaluation with arbitrated cervicography interpretations. Am J Obstet Gynecol 2002;187:15-23.
29. Wertlake PT, Francus K, Newkirk GR, Parham GP. Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: A community-based clinical trial. Obstet Gynecol 1997;90:421-7.
30. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol 1999;181:560-6.
31. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-6.
32. Solomon D, Schiffman M, Tarrone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
33. [33J Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000;124:672-81.
34. Edwards G, Rutkowski C. Cervical cancer screening with Papanicolaou smear plus speculoscopy by nurse practitioners in a health maintenance organization. J Lower Gen Tract Dis 1997;1:141-7.
35. Loiudice L, Abbiati R, Boselli F, et al. Improvement of Pap smear sensitivity using a visual adjunctive procedure: A co-operative Italian study on speculoscopy (GISPE). Eur J Cancer Prev 1998;7:295-304.
36. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-5.
37. Parham GP, Andrews NR, Lee ML. Comparison of immediate and deferred colposcopy in a cervical screening program. Obstet Gynecol 2000;95:340-4.
38. Lonky N, Edwards G. Comparison of chemiluminescent light versus incandescent light in the visualization of acetowhite epithelium. Am J Gynecol Health 1992;6:11-5.
39. Suneja A, Mahishee, Agarwal N, Misra K. Comparison of magnified chemiluminescent examination with incandescent light examination and colposcopy for detection of cervical neoplasia. Indian J Cancer 1998;35:81-7.
40. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
41. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
42. Bosch FX, de Sanjose S, Castellsague X, Munoz N. Geographical and social patterns of cervical cancer incidence. In: Franco E, Monsonego J, editors. New Developments in Cervical Cancer Screening and Prevention. London: Blackwell Scientific Ltd; 1997. p. 23-33.
43. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
44. Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deals, costs, and quality of life up to the year 2017. Acta Oncologica 1997;36(Supplement 9):1-60.
45. UNAIDS. AIDS Epidemic Update: December 2001. Geneva: UNAIDS/WHO; 2001.
46. Richart RM. Screening: The next century. Cancer 1995;76:1919-27.
47. Miller AB. Cervical Cancer Screening Programmes: Managerial Guidelines. Geneva: World Health Organization; 1992.
48. Olatunbosun OA, Okonofua FE, Ayangade SO. Outcome of cryosurgery for cervical intraepithelial neoplasia in a developing country. Int J Gynaecol Obstet 1992;38:305-10.
49. Ostergard DR. Cryosurgical treatment of cervical intraepithelial neoplasia. Obstet Gynecol 1980;56:231-3.
50. Creasman WT, Hinshaw WM, Clarke-Pearson DL. Cryosurgery in the management of cervical intraepithelial neoplasia. Obstet Gynecol 1984;63:145-9.
51. Denny L, Kuhn L, Risi L, et al. Two-stage cervical cancer screening: An alternative for resourcepoor settings. Am J Obstet Gynecol 2000;183:383-8.
52. Blumenthal PD, Gaffikin L, Chirenje ZM, McGrath J, Womack S, Shah K. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet 2001;72:47-53.
53. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness. JAMA 2001;285:3107-15.
54. Coppleson M, Reid BL, Skladnev VN, Dalrymple JC. An electronic approach to the detection of pre-cancer and cancer of the uterine cervix: A preliminary evaluation of Polarprobe. Int J Gynecol Cancer 1994;4:79-83.
55. Quek SC, Mould T, Canfell K, Singer A, Skladnev V, Coppleson M. The Polarprobe: Emerging technology for cervical cancer screening. Ann Acad Med Singapore 1998;27:717-21.
56. Ramanujam N, Mitchell MF, Mahadeven A, Thomsen S, Silva E, Richards-Kortum R. Fluorescence spectroscopy: A diagnostic tool for cervical intraepithelial neoplasia (CIN). Gynecol Oncol 1994;52:31-8.
57. Ramanujam N, Mitchell MF, Mahadevan-Jansen A, et al. Cervical precancer detection using a multivariate statistical algorithm based on laser-induced fluorescence spectra at multiple excitation wavelengths. Photochem Photobiol 1996;64:720-5.
58. Marchesini R, Brambilla M, Pignoli E, et al. Light-induced fluorescence spectroscopy of human colonic mucosa. J Photochem Photobiol 1992;14:219-30.
59. Burke L, Modell M, Niloff J, Kobelin M, Abu-Jawdeh G, Zelenchuk A. Identification of squamous intraepithelial lesions: Fluorescence of cervical tissue during colposcopy. J Lower Gen Tract Dis 1999;3:159-62.
60. Mitchell MF, Cantor SB, Ramanujam N, Tortolero-Luna G, Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1999;93:462-70.
61. Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neooplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994;44:836-41.
62. Hillemanns P, Korell M, Schmitt-Sody M, et al. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int J Cancer 1999;81:34-8.
63. Mitchell MF, Cantor SB, Brookner C, Utzinger U, Schottenfeld D, Richards-Kortum R. Screening for squamous intraepithelial lesions with fluorescence spectroscopy. Obstet Gynecol 1999;94:889-96.